Literature DB >> 7859365

Effects of prolonged (1 year) choline deficiency and subsequent re-feeding of choline on 1,2-sn-diradylglycerol, fatty acids and protein kinase C in rat liver.

K A da Costa1, S C Garner, J Chang, S H Zeisel.   

Abstract

Rats fed a choline-deficient diet develop foci of enzyme-altered hepatocytes with subsequent formation of hepatic tumors. They also develop fatty livers, because choline is needed for hepatic secretion of lipoproteins. We have previously reported that 1,2-sn-diradylglycerol accumulates in the livers of rats fed a choline-deficient diet for 1-27 weeks, and that protein kinase C activity in the hepatic plasma membrane is elevated during that time (da Costa et al., J. Biol. Chem., 268, 2100-2105, 1993). In the present study, we examined the changes that occur in rat liver at 52 weeks of choline deficiency and determined whether these changes were reversible when choline was returned to the diet of the deficient animals for 1 or 16 weeks. At 52 weeks, non-tumor liver samples from the experimental animals had increased 1,2-sn-diradylglycerol concentrations in the lipid droplets compared with control animals. Plasma membrane 1,2-sn-diradylglycerol levels in the liver did not differ between the two groups, but an age-related increase in membrane 1,2-sn-diradylglycerol concentrations was observed. Unsaturated free fatty acids, another activator of protein kinase C, accumulated in the deficient livers. Protein kinase C activity associated with the plasma membrane remained significantly elevated at 52 weeks in deficient livers. Hepatic foci expressing gamma-glutamyltranspeptidase were detected only in the deficient rats (0.83% of liver volume) and 15% of these rats had hepatocellular carcinoma at 1 year on the diet. At 53 weeks (1 week after choline was returned to the deficient group), 1,2-sn-diradylglycerol concentrations in the lipid droplets and hepatic free fatty acids had dropped to control levels. By 68 weeks (16 weeks of re-feeding choline), the membrane protein kinase C activity had returned to normal. At this time, 14% of the experimental animals had hepatocellular carcinoma. We suggest that choline deficiency altered the protein kinase C-mediated signal transduction within liver and this contributed to hepatic carcinogenesis in these animals.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7859365     DOI: 10.1093/carcin/16.2.327

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  13 in total

1.  Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies.

Authors:  Allyson K Martínez; Luca Maroni; Marco Marzioni; Syed T Ahmed; Mena Milad; Debolina Ray; Gianfranco Alpini; Shannon S Glaser
Journal:  Curr Pathobiol Rep       Date:  2014-12-01

2.  Choline prevents fetal overgrowth and normalizes placental fatty acid and glucose metabolism in a mouse model of maternal obesity.

Authors:  Juha Nam; Esther Greenwald; Chauntelle Jack-Roberts; Tamara T Ajeeb; Olga V Malysheva; Marie A Caudill; Kathleen Axen; Anjana Saxena; Ekaterina Semernina; Khatia Nanobashvili; Xinyin Jiang
Journal:  J Nutr Biochem       Date:  2017-08-12       Impact factor: 6.048

Review 3.  Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression.

Authors:  Karen D Corbin; Steven H Zeisel
Journal:  Curr Opin Gastroenterol       Date:  2012-03       Impact factor: 3.287

Review 4.  Dietary choline deficiency causes DNA strand breaks and alters epigenetic marks on DNA and histones.

Authors:  Steven H Zeisel
Journal:  Mutat Res       Date:  2011-10-20       Impact factor: 2.433

5.  Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD).

Authors:  Jiannan Song; Kerry Ann da Costa; Leslie M Fischer; Martin Kohlmeier; Lester Kwock; Shuli Wang; Steven H Zeisel
Journal:  FASEB J       Date:  2005-08       Impact factor: 5.191

6.  High intakes of choline and betaine reduce breast cancer mortality in a population-based study.

Authors:  Xinran Xu; Marilie D Gammon; Steven H Zeisel; Patrick T Bradshaw; James G Wetmur; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella; Jia Chen
Journal:  FASEB J       Date:  2009-07-27       Impact factor: 5.191

Review 7.  Choline, Other Methyl-Donors and Epigenetics.

Authors:  Steven Zeisel
Journal:  Nutrients       Date:  2017-04-29       Impact factor: 5.717

Review 8.  Methyl Donor Micronutrients that Modify DNA Methylation and Cancer Outcome.

Authors:  Abeer M Mahmoud; Mohamed M Ali
Journal:  Nutrients       Date:  2019-03-13       Impact factor: 5.717

Review 9.  Fat and Sugar-A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver Disease.

Authors:  Ines C M Simoes; Justyna Janikiewicz; Judith Bauer; Agnieszka Karkucinska-Wieckowska; Piotr Kalinowski; Agnieszka Dobrzyń; Andrzej Wolski; Maciej Pronicki; Krzysztof Zieniewicz; Paweł Dobrzyń; Marcin Krawczyk; Hans Zischka; Mariusz R Wieckowski; Yaiza Potes
Journal:  Nutrients       Date:  2019-11-24       Impact factor: 5.717

10.  Drug-induced and postnatal hypothyroidism impairs the accumulation of diacylglycerol in liver and liver cell plasma membranes.

Authors:  Oksana A Krasilnikova; Nataliya S Kavok; Nataliya A Babenko
Journal:  BMC Physiol       Date:  2002-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.